Neuroendocrine Neoplasms Methylation Based Classifier - The NEMESIs-study
NCT05013957
·
clinicaltrials.gov ↗
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DIAGNOSTIC_TEST:
Methylation analysis
Sponsor
University Hospital, Basel, Switzerland